490
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate

, , , &
Pages 650-658 | Received 17 Mar 2011, Accepted 04 Jul 2011, Published online: 09 Aug 2011

References

  • Bitz C, Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int J Pharm 1996; 131: 171–81
  • Bienová M, Kucerová R, Fiurasková M, Hajdúch M, Kolár Z. Androgenic alopecia and current methods of treatment. Acta Dermatovenerol Alp 2005; 14: 5–8
  • Buhl AE, Waldon, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol 1990; 95: 533–7
  • Cevher E, Orhan Z, Mülazimoğlu L, Sensoy D, Alper M, Yildiz A, Ozsoy Y. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm 2006; 317: 127–35
  • De Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm 2001; 226: 181–4
  • De Santana DC, Pupo TT, Sauaia MG, da Silva RS, Lopez RF. Nitric oxide photorelease from hydrogels and from skin containing a nitro-ruthenium complex. Int J Pharm 2010; 391: 218
  • FDA (U.S. Food and Drug Administration) Guidance for industry: analytical procedures and methods validation. 2000. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM122858.pdf (accessed 12 September 2009).
  • Gao F, Kodama T, Chen X, Okada K, Honda T. A targeting approach for delivery of polymer microparticle-antibody conjugate against Vibrio parahaemolyticus-induced cytotoxicity to human intestinal epithelial cells. J Drug Target 2007; 15: 428–36
  • Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008; 69: 1–9
  • Gavini E, Rassu G, Muzzarelli C, Cossu M, Giunchedi P. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur J Pharm Biopharm 2008; 68: 245–52
  • Gelfuso GM, Figueiredo FV, Gratieri T, Lopez RF. The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4). J Pharm Sci 2008; 97: 4249–57
  • Gelfuso GM, Gratieri T, Souza JG, Thomazine JA, Lopez RF. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy. Eur J Pharm Biopharm 2011; 77: 249–56
  • Gribanov AV, Sazanov YN. Polyacrylonitrile: carbonization problems. Russ J Appl Chem 2008; 81: 919–32
  • Higuchi WI. Analysis of data on medicament release from ointments. J Pharm Sci 1962; 51: 802
  • Intra J, Salem AK, Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells. J Drug Target, 2010 [Epub ahead of print]
  • Ji JJ, Ding ZJ, Yang XL. Preparation and properties of chitosan film as a drug sustained-release system. West China Journal of Stomatology 2009; 27: 248–51
  • Lopez RF, Seto JE, Blankschtein D, Langer R. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials 2011; 32: 933–41
  • Meidan VM, Bonner MC, Michiniak BB. Transfollicular drug delivery—is it a reality?. Int J Pharm 2005; 306: 1–14
  • Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004; 150: 186–94
  • Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis ChC, Blume-Peytavi U, et al. Ru 58841-myristate-prodrug development for topical treatment of acneand androgenetic alopecia. Pharmazie 2005; 60: 8–12
  • Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine 2007; 3: 173–83
  • Oliveira BF, De Santana MHA, Ré MI. Spray-dried chitosan microspheres as a pDNA carrier. Drying Technol 2006; 24: 373–82
  • Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters. AAPS PharmSciTech 2003; 4: E13
  • Pitaksuteepong T, Somsiri A, Waranuch N. Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles. Eur J Pharm Biopharm 2007; 67: 639–45
  • Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EM, Yoong C, Robertson TA, Soyer HP, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Del Rev, 2011 [Epub ahead of print]
  • Shah PP, Mashru RC, Thakkar AR, Badhan AC. Effect of chitosan crosslinking on bitterness of artemether using response surface methodology. J Pharm Pharmacol 2008; 60: 421–7
  • Shim J, Seok H, Shim J, Seok Kang H, Park WS, Han SH, Kim J, Chang IS. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release 2004; 97: 477–84
  • Smijs TG, Bouwstra JA. Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J Biom Nanotechnol 2010; 6: 469–84
  • Tran V-T, Benoît J-P, Venier-Julienne M-C. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?. Int J Pharm 2011; 407: 1–11
  • Toll R, Jacobi U, Richter H, Ladermann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004; 123: 168–76
  • Wu X, Landfester K, Musyanovych A, Guy RH. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol 2010; 23: 117–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.